CHMP4C (Charged multivesicular body protein 4c) is a gene. In the public catalogues the evidence so far is association rather than a proven role.
Probable core component of the endosomal sorting required for transport complex III (ESCRT-III) which is involved in multivesicular bodies (MVBs) formation and sorting of endosomal cargo proteins into MVBs. MVBs contain intraluminal vesicles (ILVs) that are generated by invagination and scission from the limiting membrane of the endosome and mostly are delivered to lysosomes enabling degradation of membrane proteins, such as stimulated growth factor receptors, lysosomal enzymes and lipids. The MVB pathway appears to require the sequential function of ESCRT-O, -I,-II and -III complexes.
Open Targets scores its association with cancer at 0.53 (direct and indirect evidence; datatypes literature 0.91, genetic association 0.66).
In plain words · CHMP4C (Charged multivesicular body protein 4c) is a gene. In the public catalogues the evidence so far is association rather than a proven role.
CHMP4C (Charged multivesicular body protein 4c) is a gene. In the public catalogues the evidence so far is association rather than a proven role.
Probable core component of the endosomal sorting required for transport complex III (ESCRT-III) which is involved in multivesicular bodies (MVBs) formation and sorting of endosomal cargo proteins into MVBs.
No product in this corpus aims at CHMP4C yet. Drugs bind the molecule precisely: to switch it off, flag the cell for the immune system, or deliver a payload.
First described 2004. Earliest sequence paper UniProt cites for the protein: Katoh et al, Arch. Biochem. Biophys, 2004, "CHMP4b is a major binding partner of the ALG-2-interacting protein Alix among the three CHMP4 isoforms". Source.
Sources: HGNC HGNC:30599 (approved symbol, name, aliases, locus and cross-references (hgnc_complete_set.txt)); UniProt Q96CF2 (protein name, function text, keywords and locations (REST API)); Open Targets ENSG00000164695 (association with cancer (MONDO_0004992) 0.53; (GraphQL API, CC0))
Probable core component of the endosomal sorting required for transport complex III (ESCRT-III) which is involved in multivesicular bodies (MVBs) formation and sorting of endosomal cargo proteins into MVBs. MVBs contain intraluminal vesicles (ILVs) that are generated by invagination and scission from the limiting membrane of the endosome and mostly are delivered to lysosomes enabling degradation of membrane proteins, such as stimulated growth factor receptors, lysosomal enzymes and lipids. The MVB pathway appears to require the sequential function of ESCRT-O, -I,-II and -III complexes. ESCRT-III proteins mostly dissociate from the invaginating membrane before the ILV is released. The ESCRT machinery also functions in topologically equivalent membrane fission events, such as the terminal stages of cytokinesis and the budding of enveloped viruses (HIV-1 and other lentiviruses). Key component of the cytokinesis checkpoint, a process required to delay abscission to prevent both premature resolution of intercellular chromosome bridges and accumulation of DNA damage: upon phosphorylation by AURKB, together with ZFYVE19/ANCHR, retains abscission-competent VPS4 (VPS4A and/or VPS4B) at the midbody ring until abscission checkpoint signalling is terminated at late cytokinesis. Location: Cytoplasm, cytosol; Late endosome membrane; Midbody, Midbody ring (UniProt). Locus 8q21.13 (HGNC).
Query for this target: (TITLE:"CHMP4C" OR ABSTRACT:"CHMP4C" OR TITLE:"charged multivesicular body protein 4C" OR ABSTRACT:"charged multivesicular body protein 4C" OR TITLE:"Charged multivesicular body protein 4c" OR ABSTRACT:"Charged multivesicular body protein 4c" OR TITLE:"MGC22825" OR ABSTRACT:"MGC22825" OR TITLE:"Shax3" OR ABSTRACT:"Shax3" OR TITLE:"VPS32C" OR ABSTRACT:"VPS32C") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about CHMP4C, not a curated reading list.